Targeting a MicroRNA Shows Potential to Enhance Effectiveness of Diabetes Drugs


 

Over the past 15 years, UAB endocrinologist Anath Shalev, MD has unraveled a crucial biological pathway that malfunctions in diabetes.

Her latest discovery in this beta-cell pathway, published in the journal Diabetes, shows the potential to enhance the effectiveness of existing diabetes drugs.

In 2013, the UAB researchers found that either diabetes or elevated production of the protein TXNIP induced beta-cell expression of microRNA-204, or miR-204, and this microRNA, in turn, blocked insulin production.

The Shalev group has now found another vital role for miR-204 -- regulating the cell surface receptor that is the target of many of the newer type 2 diabetes drugs. This drug target is the glucagon-like peptide 1 receptor, or GLP1R. Activation of GLP1R with these drugs helps the beta cell produce and secrete more insulin.

Shalev's new work was performed in rat beta cells, genetically modified mice, mouse pancreatic islets and human pancreatic islets. Healthy beta cells, which are found in the pancreatic islets, produce insulin to control blood sugar levels; in diabetes the beta cells are impaired and dysfunctional, and have lower GLP1R levels.

Shalev and colleagues found that overexpression of miR-204 decreased expression of GLP1R in rat beta cells and in mouse and human pancreatic islets. Conversely, knock-down of miR-204 increased expression of GLP1R in those cells and pancreatic islets.

Greater GLP1R expression is beneficial because it helps transfer a signal to the beta cell to secrete more insulin, such as after a meal. Also, many of the newer diabetes drugs act as agonists to activate GLP1R. Higher expression can allow use of a lower-drug dose to treat diabetes, thus reducing dose-dependent side effects.

In mice, the UAB researchers found that a deletion of miR-204 caused enhanced GLP1R expression, and also better insulin secretion and glucose control. Furthermore, the knockout mice were more responsive to a GLP1R agonist in glucose tolerance tests. When the GLP1R knockout mice were used in a model of diabetes, where beta cells are damaged by low doses of the toxin streptozotocin, the diabetic mice showed improved glucose control and increased serum insulin levels.

These results suggest that downregulating miR-204, now revealed as an upstream regulator of GLP1R, could lead to better treatment of diabetes.

 
Share:

 

More Grand Rounds:

 

Overstreet Joins Burr Forman Health Law Practice

Overstreet Joins Burr Forman Health Law Practice

Adam Overstreet has joined Burr & Forman where he will practice with firm's health care group in Birmingham.

Read More

Cisco names TekLinks South Collaboration Partner of the Year

Cisco recently recognized TekLinks as the South Area Architectural Excellence - Collaboration Partner of the Year.

Read More

DCH Introduces Human Milk Program for Premature Infants

DCH Introduces Human Milk Program for Premature Infants

DCH Health System has launched a donor breast milk program benefitting premature infants in the neonatal intensive care units (NICUs) at DCH Regional Medical Center and Northport Medical Center.

Read More

St. Vincent's Open Urgent Care in Homewood

St. Vincent's Open Urgent Care in Homewood

St. Vincent's Health System recently held a ribbon cutting for the opening of its new St. Vincent's Urgent Care location in Homewood.

Read More

Targeting a MicroRNA Shows Potential to Enhance Effectiveness of Diabetes Drugs

Over the past 15 years, UAB endocrinologist Anath Shalev, MD has unraveled a crucial biological pathway that malfunctions in diabetes.

Read More

Study Finds Dieting Combined with High-Intensity Exercise Helps Reducing Risk of Weight Regain

Researchers at UAB have found that combining a calorie-restricted diet with high-intensity interval training could be a solution for reducing weight regain after weight loss.

Read More

St. Vincent's Primary Care Adds New Physicians

St. Vincent's Primary Care Adds New Physicians

St. Vincent's Primary Care, a service of St. Vincent's Health System, has recently added one existing practice and three new physicians to their network.

Read More

Mona Fouad, MD is Honored

Mona Fouad, MD is Honored

Mona N. Fouad, MD, professor and director of the Division of Preventive Medicine in the UAB School of Medicine, has been elected as a member of the National Academy of Medicine -- one of the highest honors given to a physician or scientist in the United States.

Read More

Wilson Joins Alabama Allergy & Asthma

Wilson Joins Alabama Allergy & Asthma

Lorena Wilson, MD has joined Alabama Allergy & Asthma Center, and is seeing patients at the Homewood, Hoover and Alabaster locations.

Read More

Bryant Promoted to COO of Grandview

Bryant Promoted to COO of Grandview

Justin Bryant has been promoted to Chief Operating Officer of Grandview Medical Center. He succeeds Drew Mason who was recently promoted to CEO.

Read More

UAB Medicine Opens New Outpatient Clinics

UAB Medicine Opens New Outpatient Clinics

UAB has added 28,600 square feet of clinical space with expansion into the John N. Whitaker Building, which sits just east of the Kirklin Clinic parking deck.

Read More

Researchers Awarded $5.7 Million

Researchers Awarded $5.7 Million

Researchers studying methods of exercise delivery and the effects on people living with multiple sclerosis have been awarded $5.7 million in funding by the Patient-Centered Outcomes Research Institute (PCORI).

Read More

Shelby Baptist Obtains New Robotic System

Shelby Baptist Obtains New Robotic System

Shelby Baptist Medical Center has acquired the new da Vinci Xi Surgical System, further complementing the hospital's minimally-invasive robotic surgery capabilities.

Read More

Biotech Veteran Jay Liu Joins Southern Research

Jay Liu, PhD has joined the Southern Research Drug Discovery division as director of technology development and innovation. Liu will seek to expand Southern Research's drug discovery capabilities in areas that include biologics and monoclonal antibodies.

Read More

UAB Breaks Ground on New Facility

UAB has broken ground for a new freestanding emergency department and adjacent medical office building in Gardendale.

Read More

St. Vincent's Health System to Adopt Ascension as Part of its Name

St. Vincent's Health System (STVHS) will add Ascension to its name as part of a national effort to make it clearer for patients to access care.

Read More

UAB Listed in 100 hospitals with Great Heart Programs

Becker's Healthcare has named UAB Hospital to the 2017 edition of its list of "100 hospitals and health systems with great heart programs."

Read More

Blue Cross and Blue Shield of Alabama Partners With axialHealthcare

Blue Cross and Blue Shield of Alabama is partnering with axialHealthcare, a national leader in pain management, to collaborate with Alabama physicians to help curb the opioid epidemic.

Read More

Mason Promoted to CEO of Grandview Medical Center

Mason Promoted to CEO of Grandview Medical Center

Drew Mason has been promoted to Chief Executive Officer of Grandview Medical Center. He succeeds Keith Granger who was promoted to the position of CHSPSC, LLC Regional President and Market CEO of Alabama.

Read More

HudsonAlpha and CHDI Foundation Announce Huntington Disease Collaboration

HudsonAlpha Institute for Biotechnology and CHDI Foundation have announced a research collaboration to study the gene regulatory network controlling the expression of the huntingtin (HTT) gene that, when mutated, causes Huntington disease, a neurodegenerative disorder characterized by the progressive breakdown of nerve cells in the brain. Richard Myers, PhD, president of HudsonAlpha is leading the project along with senior scientist Brian Roberts.

Read More

 

Email Print
 

Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: